New treatments and blood tests could change detection and treatments. New treatments and simple blood tests could change how doctors detect and treat Alzheimer's disease, according to a new report ...

Alzheimer's pathology was common in other dementias. An Alzheimer's biomarker profile was seen in unspecified dementia, Parkinson's dementia, and frontotemporal dementia. Biomarkers indicating ...

Image credit: Ippei Naoi/Getty Images. About 32 million people around the world live with Alzheimer’s disease. Past studies show that disease-related biomarkers may be found years before the ...

Apr. 30, 2025 — An increase in physical activity between the ages of 45 and 65 could help prevent Alzheimer's disease, while inactivity may be detrimental to brain ... New Body-Fluid Biomarker ...

A new study says that some risk factors and blood biomarkers related to Alzheimer’s disease and cognitive impairment can be detected as early as age 24. Alzheimer’s disease is normally not ...

Michael Hornberger is the author of Tangled Up: The History and Science of Alzheimer's Disease, published by Canbury Press. Ever heard of Fischer’s disease? No? Maybe that is not surprising ...

One of the earliest and most frequently overlooked signs of Alzheimer’s disease involves subtle difficulties with spatial navigation, particularly in previously familiar environments.

About three years ago, at age 46, he was diagnosed with early-onset Alzheimer’s disease. Although Rios has been doing well on a new treatment he receives through a clinical trial, Ribot is ...

About three years ago, at age 46, he was diagnosed with early-onset Alzheimer’s disease. Although Rios has been doing well on a new treatment he receives through a clinical trial, Ribot is ...

The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness even without carrying the well-known mutations linked to it.

AI Helps Unravel a Cause of Alzheimer's Disease and Identify a Therapeutic Candidate Apr. 25, 2025 — A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears to slow memory loss, giving patients the gift of more time.